{"id":342387,"date":"2025-08-20T17:56:35","date_gmt":"2025-08-20T17:56:35","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-beam-therapeutics\/"},"modified":"2025-08-20T17:56:35","modified_gmt":"2025-08-20T17:56:35","slug":"how-to-buy-beam-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/","title":{"rendered":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Beam Therapeutics Inc. (BEAM) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. Bu yenilik\u00e7i gen d\u00fczenleme hissesi i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Beam Therapeutics Inc. (BEAM) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m rehberimizle \u00f6\u011frenin. Bu yenilik\u00e7i gen d\u00fczenleme hissesi i\u00e7in g\u00fcncel fiyat, riskler ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Genetik t\u0131bb\u0131n gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Beam Therapeutics, sa\u011fl\u0131k hizmetlerini devrim niteli\u011finde de\u011fi\u015ftirebilecek gen d\u00fczenleme teknolojisinin \u00f6nc\u00fcs\u00fcd\u00fcr. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil; hassas t\u0131pta potansiyel bir oyun de\u011fi\u015ftiricidir. BEAM'e yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi, mevcut performanstan uzun vadeli beklentilere kadar detayl\u0131ca a\u00e7\u0131klayaca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"Genetik t\u0131bb\u0131n gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Beam Therapeutics, sa\u011fl\u0131k hizmetlerini devrim niteli\u011finde de\u011fi\u015ftirebilecek gen d\u00fczenleme teknolojisinin \u00f6nc\u00fcs\u00fcd\u00fcr. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil; hassas t\u0131pta potansiyel bir oyun de\u011fi\u015ftiricidir. BEAM'e yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi, mevcut performanstan uzun vadeli beklentilere kadar detayl\u0131ca a\u00e7\u0131klayaca\u011f\u0131z."},"body_html":"<h2>Mevcut Piyasa Konumu ve Giri\u015f Noktas\u0131<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla Beam Therapeutics Inc. (BEAM) hisseleri <strong>16,35 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hisse senedinin sadece alt\u0131 ay \u00f6nce \u015eubat 2025'te 52 haftal\u0131k zirvesi olan 35,25 $ seviyesine ula\u015fmas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda \u00f6nemli bir f\u0131rsat sunuyor<a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>4 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin - Beam Therapeutics'in 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn<a href=\"https:\/\/public.com\/stocks\/beam\/earnings\">Public.com<\/a>. Tarihsel olarak, biyoteknoloji kazan\u00e7lar\u0131 fiyatlarda dramatik hareketlere neden olabilir.<\/p> <table> <thead> <tr> <th>Tarih<\/th> <th>Olay<\/th> <th>Haber \u00d6ncesi Fiyat<\/th> <th>Haber Sonras\u0131 De\u011fi\u015fim<\/th> <\/tr> <\/thead> <tbody> <tr> <td>5 A\u011fu 2025<\/td> <td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>17,82 $<\/td> <td>%8,2 d\u00fc\u015f\u00fc\u015f (gelir hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td> <\/tr> <tr> <td>May\u0131s 2025<\/td> <td>\u00d6nceki Kazan\u00e7lar<\/td> <td>~26,50 $<\/td> <td>%20 d\u00fc\u015f\u00fc\u015f<\/td> <\/tr> <tr> <td>18 \u015eub 2025<\/td> <td>Klinik Veriler<\/td> <td>29,05 $<\/td> <td>%21 art\u0131\u015f ile 35,25 $ zirve<\/td> <\/tr> <tr> <td>Mar 2025<\/td> <td>Olumsuz Haber<\/td> <td>35,25 $<\/td> <td>%15,7 d\u00fczeltme<\/td> <\/tr> <tr> <td>7 Nis 2025<\/td> <td>Piyasa Dip Seviyesi<\/td> <td>\u00c7e\u015fitli<\/td> <td>13,52 $ dip seviyesi<\/td> <\/tr> <\/tbody> <\/table> <p>Bu desen, klinik ve finansal duyurular etraf\u0131nda a\u015f\u0131r\u0131 volatiliteyi g\u00f6steriyor - geli\u015fim a\u015famas\u0131ndaki biyoteknolojiler i\u00e7in tipiktir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalarla Dolu Bir S\u00fcr\u00fc\u015f<\/h2> <p>BEAM'in Mart-A\u011fustos 2025 performans\u0131 olduk\u00e7a dramatikti:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: Zirve heyecan\u0131 - hisse pozitif klinik verilerle 35,25 $ seviyesine ula\u015ft\u0131<\/li> <li><strong>Mart 2025<\/strong>: Ger\u00e7eklik kontrol\u00fc - %15,68 d\u00fczeltme ile 29,05 $ seviyesine indi<\/li> <li><strong>Nisan 2025<\/strong>: Dip nokta - 52 haftal\u0131k en d\u00fc\u015f\u00fck 13,52 $ seviyesine d\u00fc\u015ft\u00fc<\/li> <li><strong>May\u0131s-A\u011fustos 2025<\/strong>: \u0130yile\u015fme d\u00f6nemi - mevcut 16,35 $ seviyesine geri t\u0131rmand\u0131<\/li> <\/ul> <p>Alt\u0131 ayl\u0131k performans genel olarak <strong>%25,55 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6steriyor, ancak Nisan diplerinden toparlanma <strong>%21'lik bir s\u0131\u00e7rama<\/strong> anlam\u0131na geliyor<a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>. Bu volatilite, biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n g\u00fc\u00e7l\u00fc sinirler ve dikkatli zamanlama gerektirmesinin tam sebebidir.<\/p> <h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve klinik d\u00f6n\u00fcm noktalar\u0131na dayanarak, bekleyebilecekleriniz:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 18-22 $ aral\u0131\u011f\u0131 (denemeler ilerledik\u00e7e \u0131l\u0131ml\u0131 toparlanma)<\/li> <li><strong>2026 Hedefi<\/strong>: 24-28 $ (BEAM-101 BLA ba\u015fvurusu bekleniyor)<a href=\"https:\/\/gov.capital\/stock\/beam-stock\/\">Gov.Capital<\/a><\/li> <li><strong>2028 Projeksiyonu<\/strong>: 35-45 $ (potansiyel ilk ticari onaylar)<\/li> <li><strong>2030 Vizyonu<\/strong>: 50-80+ $ (platform teknolojisi ba\u015far\u0131l\u0131 olursa)<a href=\"https:\/\/stockanalysis.com\/stocks\/beam\/forecast\/\">StockAnalysis<\/a><\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in ALIN<\/strong> - ancak sadece kaybetmeyi g\u00f6ze alabilece\u011finiz risk sermayesi ile.<\/p> <h2>\u26a0\ufe0f Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Temel Riskler<\/h2> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Deneysel ila\u00e7lar\u0131n %90'\u0131 ba\u015far\u0131s\u0131z olur - BEAM'in t\u00fcm de\u011feri ba\u015far\u0131l\u0131 denemelere ba\u011fl\u0131d\u0131r<\/li> <li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez ve y\u0131llar alabilir<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: Y\u0131ll\u0131k 400 milyon $ Ar-Ge harcamas\u0131 s\u00fcrekli finansman gerektirir<a href=\"https:\/\/www.ainvest.com\/news\/beam-therapeutics-narrower-loss-q2-2025-sign-sustainable-turnaround-temporary-bounce-2508\/\">AInvest<\/a><\/li> <li><strong>Rekabet<\/strong>: CRISPR Therapeutics gibi devler zaten onayl\u0131 \u00fcr\u00fcnlere sahip<\/li> <li><strong>Hisse Seyrelme Riski<\/strong>: Y\u00fcksek nakit t\u00fcketimi ek hisse arzlar\u0131n\u0131 gerektirebilir<\/li> <\/ul> <h2>\ud83d\udfe2 2025 B\u00fcy\u00fcmesi \u0130\u00e7in Olumlu Sinyaller<\/h2> <ul> <li><strong>Klinik \u0130lerleme<\/strong>: BEAM-302, zararl\u0131 proteinlerde %78 azalma ve hafif yan etkiler g\u00f6sterdi<\/li> <li><strong>Nakit Rezervi<\/strong>: 1,2 milyar $ rezerv, operasyonlar\u0131 2028'e kadar finanse ediyor<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a><\/li> <li><strong>Teknoloji Avantaj\u0131<\/strong>: Baz d\u00fczenleme, geleneksel CRISPR y\u00f6ntemlerinden daha g\u00fcvenlidir<\/li> <li><strong>Piyasa Konumu<\/strong>: Yeni nesil gen d\u00fczenlemede ilk hareket eden<\/li> <li><strong>\u00dcr\u00fcn \u00c7e\u015fitlili\u011fi<\/strong>: Birden fazla program tek nokta ba\u015far\u0131s\u0131zl\u0131k riskini azalt\u0131r<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferde b\u00fcy\u00fck al\u0131m yerine k\u00fc\u00e7\u00fck par\u00e7alar halinde sat\u0131n al\u0131n<\/li> <li><strong>Stop-Loss Belirleyin<\/strong>: Felaket d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 kendinizi koruyun<\/li> <li><strong>Kataliz\u00f6rleri Takip Edin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve klinik g\u00fcncellemeleri izleyin<\/li> <\/ol> <p>Espiri: \"BEAM'e yat\u0131r\u0131m yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - inan\u0131lmaz heyecan verici potansiyel, ancak duygusal dalgalanmalara ve i\u015fe yaramayabilecek pahal\u0131 bulu\u015fmalara haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir Ticaret Platformu Se\u00e7in<\/td> <td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap Kurulumunu Tamamlay\u0131n<\/td> <td>Kimlik ve finansman bilgilerini sa\u011flay\u0131n<\/td> <\/tr> <tr> <td>3<\/td> <td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td> <td>Ger\u00e7ek zamanl\u0131 fiyat\u0131 16,35 $ (20 A\u011fu itibar\u0131yla) kontrol edin<\/td> <\/tr> <tr> <td>4<\/td> <td>Limit Emri Verin<\/td> <td>\u00d6demeye raz\u0131 oldu\u011funuz maksimum fiyat\u0131 belirleyin<\/td> <\/tr> <tr> <td>5<\/td> <td>Pozisyonu Takip Edin<\/td> <td>Performans\u0131 izleyin ve uyar\u0131 e\u015fiklerini ayarlay\u0131n<\/td> <\/tr> <\/tbody> <\/table> <h2>Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Pocket Option Neden Uygun?<\/h2> <p>Beam Therapeutics gibi yenilik\u00e7i \u015firketlere yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum 5 $ depozito<\/strong> - b\u00fcy\u00fck risk olmadan biyoteknoloji yat\u0131r\u0131m stratejilerini test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - basit belge y\u00fckleme ile dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li> <li><strong>Esnek ticaret se\u00e7enekleri<\/strong> - hem geleneksel yat\u0131r\u0131m hem de h\u0131zl\u0131 ticaret f\u0131rsatlar\u0131na eri\u015fim<\/li> <li><strong>K\u00fcresel eri\u015filebilirlik<\/strong> - yerel \u00f6deme y\u00f6ntemleriyle bir\u00e7ok \u00fclkede kullan\u0131labilir<\/li> <\/ul> <h2>2025'te Beam Therapeutics: Gen D\u00fczenlemede \u00d6nc\u00fc<\/h2> <p>Beam Therapeutics, genetik t\u0131p devriminin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirket, <strong>baz d\u00fczenleme teknolojisi<\/strong> konusunda uzmanla\u015fm\u0131\u015ft\u0131r - geleneksel CRISPR gen d\u00fczenlemesine g\u00f6re daha hassas ve g\u00fcvenli bir alternatiftir<a href=\"https:\/\/beamtx.com\/science\/\">BeamTx<\/a>. DNA zincirlerini kesmek yerine, baz d\u00fczenleme genetik yap\u0131y\u0131 k\u0131rmadan tek harf de\u011fi\u015fiklikleri yapar.<\/p> <p>\u00d6nde gelen programlar\u0131 \u015funlard\u0131r:<\/p> <ul> <li><strong>BEAM-101<\/strong>: Orak h\u00fccre hastal\u0131\u011f\u0131 tedavisi, umut verici erken sonu\u00e7lar g\u00f6steriyor<\/li> <li><strong>BEAM-302<\/strong>: Alfa-1 antitripsin eksikli\u011fi terapisi, \u00e7\u0131\u011f\u0131r a\u00e7an verilerle<\/li> <li><strong>CAR-T programlar\u0131<\/strong>: D\u00fczenlenmi\u015f ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri kullanarak yeni nesil kanser tedavileri<\/li> <\/ul> <p>\u015eirket, operasyonlar\u0131 2028'e kadar finanse eden <strong>1,2 milyar $ nakit pozisyonu<\/strong>na sahiptir<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a>.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025 y\u0131l\u0131nda Beam Therapeutics, baz d\u00fczenlemenin hastan\u0131n genetik kodunu hastal\u0131k yapan mutasyonu d\u00fczeltmek i\u00e7in yeniden yazabilece\u011fini klinik olarak kan\u0131tlayan ilk \u015firket oldu - genetik t\u0131bb\u0131 yeniden tan\u0131mlayabilecek bir d\u00f6n\u00fcm noktas\u0131.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Mevcut Piyasa Konumu ve Giri\u015f Noktas\u0131<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla Beam Therapeutics Inc. (BEAM) hisseleri <strong>16,35 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hisse senedinin sadece alt\u0131 ay \u00f6nce \u015eubat 2025&#8217;te 52 haftal\u0131k zirvesi olan 35,25 $ seviyesine ula\u015fmas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda \u00f6nemli bir f\u0131rsat sunuyor<a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>4 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin &#8211; Beam Therapeutics&#8217;in 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn<a href=\"https:\/\/public.com\/stocks\/beam\/earnings\">Public.com<\/a>. Tarihsel olarak, biyoteknoloji kazan\u00e7lar\u0131 fiyatlarda dramatik hareketlere neden olabilir.<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>17,82 $<\/td>\n<td>%8,2 d\u00fc\u015f\u00fc\u015f (gelir hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>\u00d6nceki Kazan\u00e7lar<\/td>\n<td>~26,50 $<\/td>\n<td>%20 d\u00fc\u015f\u00fc\u015f<\/td>\n<\/tr>\n<tr>\n<td>18 \u015eub 2025<\/td>\n<td>Klinik Veriler<\/td>\n<td>29,05 $<\/td>\n<td>%21 art\u0131\u015f ile 35,25 $ zirve<\/td>\n<\/tr>\n<tr>\n<td>Mar 2025<\/td>\n<td>Olumsuz Haber<\/td>\n<td>35,25 $<\/td>\n<td>%15,7 d\u00fczeltme<\/td>\n<\/tr>\n<tr>\n<td>7 Nis 2025<\/td>\n<td>Piyasa Dip Seviyesi<\/td>\n<td>\u00c7e\u015fitli<\/td>\n<td>13,52 $ dip seviyesi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Bu desen, klinik ve finansal duyurular etraf\u0131nda a\u015f\u0131r\u0131 volatiliteyi g\u00f6steriyor &#8211; geli\u015fim a\u015famas\u0131ndaki biyoteknolojiler i\u00e7in tipiktir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalarla Dolu Bir S\u00fcr\u00fc\u015f<\/h2>\n<p>BEAM&#8217;in Mart-A\u011fustos 2025 performans\u0131 olduk\u00e7a dramatikti:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: Zirve heyecan\u0131 &#8211; hisse pozitif klinik verilerle 35,25 $ seviyesine ula\u015ft\u0131<\/li>\n<li><strong>Mart 2025<\/strong>: Ger\u00e7eklik kontrol\u00fc &#8211; %15,68 d\u00fczeltme ile 29,05 $ seviyesine indi<\/li>\n<li><strong>Nisan 2025<\/strong>: Dip nokta &#8211; 52 haftal\u0131k en d\u00fc\u015f\u00fck 13,52 $ seviyesine d\u00fc\u015ft\u00fc<\/li>\n<li><strong>May\u0131s-A\u011fustos 2025<\/strong>: \u0130yile\u015fme d\u00f6nemi &#8211; mevcut 16,35 $ seviyesine geri t\u0131rmand\u0131<\/li>\n<\/ul>\n<p>Alt\u0131 ayl\u0131k performans genel olarak <strong>%25,55 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6steriyor, ancak Nisan diplerinden toparlanma <strong>%21&#8217;lik bir s\u0131\u00e7rama<\/strong> anlam\u0131na geliyor<a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>. Bu volatilite, biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n g\u00fc\u00e7l\u00fc sinirler ve dikkatli zamanlama gerektirmesinin tam sebebidir.<\/p>\n<h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve klinik d\u00f6n\u00fcm noktalar\u0131na dayanarak, bekleyebilecekleriniz:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 18-22 $ aral\u0131\u011f\u0131 (denemeler ilerledik\u00e7e \u0131l\u0131ml\u0131 toparlanma)<\/li>\n<li><strong>2026 Hedefi<\/strong>: 24-28 $ (BEAM-101 BLA ba\u015fvurusu bekleniyor)<a href=\"https:\/\/gov.capital\/stock\/beam-stock\/\">Gov.Capital<\/a><\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 35-45 $ (potansiyel ilk ticari onaylar)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 50-80+ $ (platform teknolojisi ba\u015far\u0131l\u0131 olursa)<a href=\"https:\/\/stockanalysis.com\/stocks\/beam\/forecast\/\">StockAnalysis<\/a><\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in ALIN<\/strong> &#8211; ancak sadece kaybetmeyi g\u00f6ze alabilece\u011finiz risk sermayesi ile.<\/p>\n<h2>\u26a0\ufe0f Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Temel Riskler<\/h2>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Deneysel ila\u00e7lar\u0131n %90&#8217;\u0131 ba\u015far\u0131s\u0131z olur &#8211; BEAM&#8217;in t\u00fcm de\u011feri ba\u015far\u0131l\u0131 denemelere ba\u011fl\u0131d\u0131r<\/li>\n<li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onaylar\u0131 \u00f6ng\u00f6r\u00fclemez ve y\u0131llar alabilir<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: Y\u0131ll\u0131k 400 milyon $ Ar-Ge harcamas\u0131 s\u00fcrekli finansman gerektirir<a href=\"https:\/\/www.ainvest.com\/news\/beam-therapeutics-narrower-loss-q2-2025-sign-sustainable-turnaround-temporary-bounce-2508\/\">AInvest<\/a><\/li>\n<li><strong>Rekabet<\/strong>: CRISPR Therapeutics gibi devler zaten onayl\u0131 \u00fcr\u00fcnlere sahip<\/li>\n<li><strong>Hisse Seyrelme Riski<\/strong>: Y\u00fcksek nakit t\u00fcketimi ek hisse arzlar\u0131n\u0131 gerektirebilir<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 2025 B\u00fcy\u00fcmesi \u0130\u00e7in Olumlu Sinyaller<\/h2>\n<ul>\n<li><strong>Klinik \u0130lerleme<\/strong>: BEAM-302, zararl\u0131 proteinlerde %78 azalma ve hafif yan etkiler g\u00f6sterdi<\/li>\n<li><strong>Nakit Rezervi<\/strong>: 1,2 milyar $ rezerv, operasyonlar\u0131 2028&#8217;e kadar finanse ediyor<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a><\/li>\n<li><strong>Teknoloji Avantaj\u0131<\/strong>: Baz d\u00fczenleme, geleneksel CRISPR y\u00f6ntemlerinden daha g\u00fcvenlidir<\/li>\n<li><strong>Piyasa Konumu<\/strong>: Yeni nesil gen d\u00fczenlemede ilk hareket eden<\/li>\n<li><strong>\u00dcr\u00fcn \u00c7e\u015fitlili\u011fi<\/strong>: Birden fazla program tek nokta ba\u015far\u0131s\u0131zl\u0131k riskini azalt\u0131r<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferde b\u00fcy\u00fck al\u0131m yerine k\u00fc\u00e7\u00fck par\u00e7alar halinde sat\u0131n al\u0131n<\/li>\n<li><strong>Stop-Loss Belirleyin<\/strong>: Felaket d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 kendinizi koruyun<\/li>\n<li><strong>Kataliz\u00f6rleri Takip Edin<\/strong>: Kas\u0131m kazan\u00e7lar\u0131 ve klinik g\u00fcncellemeleri izleyin<\/li>\n<\/ol>\n<p>Espiri: &#8220;BEAM&#8217;e yat\u0131r\u0131m yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; inan\u0131lmaz heyecan verici potansiyel, ancak duygusal dalgalanmalara ve i\u015fe yaramayabilecek pahal\u0131 bulu\u015fmalara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Kurulumunu Tamamlay\u0131n<\/td>\n<td>Kimlik ve finansman bilgilerini sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td>\n<td>Ger\u00e7ek zamanl\u0131 fiyat\u0131 16,35 $ (20 A\u011fu itibar\u0131yla) kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit Emri Verin<\/td>\n<td>\u00d6demeye raz\u0131 oldu\u011funuz maksimum fiyat\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyonu Takip Edin<\/td>\n<td>Performans\u0131 izleyin ve uyar\u0131 e\u015fiklerini ayarlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Pocket Option Neden Uygun?<\/h2>\n<p>Beam Therapeutics gibi yenilik\u00e7i \u015firketlere yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum 5 $ depozito<\/strong> &#8211; b\u00fcy\u00fck risk olmadan biyoteknoloji yat\u0131r\u0131m stratejilerini test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; basit belge y\u00fckleme ile dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li>\n<li><strong>Esnek ticaret se\u00e7enekleri<\/strong> &#8211; hem geleneksel yat\u0131r\u0131m hem de h\u0131zl\u0131 ticaret f\u0131rsatlar\u0131na eri\u015fim<\/li>\n<li><strong>K\u00fcresel eri\u015filebilirlik<\/strong> &#8211; yerel \u00f6deme y\u00f6ntemleriyle bir\u00e7ok \u00fclkede kullan\u0131labilir<\/li>\n<\/ul>\n<h2>2025&#8217;te Beam Therapeutics: Gen D\u00fczenlemede \u00d6nc\u00fc<\/h2>\n<p>Beam Therapeutics, genetik t\u0131p devriminin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirket, <strong>baz d\u00fczenleme teknolojisi<\/strong> konusunda uzmanla\u015fm\u0131\u015ft\u0131r &#8211; geleneksel CRISPR gen d\u00fczenlemesine g\u00f6re daha hassas ve g\u00fcvenli bir alternatiftir<a href=\"https:\/\/beamtx.com\/science\/\">BeamTx<\/a>. DNA zincirlerini kesmek yerine, baz d\u00fczenleme genetik yap\u0131y\u0131 k\u0131rmadan tek harf de\u011fi\u015fiklikleri yapar.<\/p>\n<p>\u00d6nde gelen programlar\u0131 \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>BEAM-101<\/strong>: Orak h\u00fccre hastal\u0131\u011f\u0131 tedavisi, umut verici erken sonu\u00e7lar g\u00f6steriyor<\/li>\n<li><strong>BEAM-302<\/strong>: Alfa-1 antitripsin eksikli\u011fi terapisi, \u00e7\u0131\u011f\u0131r a\u00e7an verilerle<\/li>\n<li><strong>CAR-T programlar\u0131<\/strong>: D\u00fczenlenmi\u015f ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri kullanarak yeni nesil kanser tedavileri<\/li>\n<\/ul>\n<p>\u015eirket, operasyonlar\u0131 2028&#8217;e kadar finanse eden <strong>1,2 milyar $ nakit pozisyonu<\/strong>na sahiptir<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a>.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025 y\u0131l\u0131nda Beam Therapeutics, baz d\u00fczenlemenin hastan\u0131n genetik kodunu hastal\u0131k yapan mutasyonu d\u00fczeltmek i\u00e7in yeniden yazabilece\u011fini klinik olarak kan\u0131tlayan ilk \u015firket oldu &#8211; genetik t\u0131bb\u0131 yeniden tan\u0131mlayabilecek bir d\u00f6n\u00fcm noktas\u0131.<\/p>\n"},"faq":[{"question":"Beam Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Beam Therapeutics hisselerini sat\u0131n almak i\u00e7in bir ticaret platformu se\u00e7in, hesap a\u00e7\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emri verin ve pozisyonunuzu takip edin."},{"question":"Beam Therapeutics'in riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, reg\u00fclasyon engelleri, y\u00fcksek nakit t\u00fcketimi, rekabet ve hisse seyrelme riski bulunmaktad\u0131r."},{"question":"Beam Therapeutics'in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 18-22 $, 2026'da 24-28 $, 2028'de 35-45 $ ve 2030'da 50-80+ $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayanlar Beam Therapeutics hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %2-5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyet ortalamas\u0131 yapmak, stop-loss belirlemek ve \u00f6nemli kataliz\u00f6rleri takip etmek \u00f6nerilir."},{"question":"Beam Therapeutics'in teknolojik avantaj\u0131 nedir?","answer":"Beam Therapeutics, baz d\u00fczenleme teknolojisi ile geleneksel CRISPR y\u00f6ntemlerine g\u00f6re daha g\u00fcvenli ve hassas gen d\u00fczenleme sunmaktad\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Beam Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Beam Therapeutics hisselerini sat\u0131n almak i\u00e7in bir ticaret platformu se\u00e7in, hesap a\u00e7\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emri verin ve pozisyonunuzu takip edin."},{"question":"Beam Therapeutics'in riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, reg\u00fclasyon engelleri, y\u00fcksek nakit t\u00fcketimi, rekabet ve hisse seyrelme riski bulunmaktad\u0131r."},{"question":"Beam Therapeutics'in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 18-22 $, 2026'da 24-28 $, 2028'de 35-45 $ ve 2030'da 50-80+ $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayanlar Beam Therapeutics hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %2-5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyet ortalamas\u0131 yapmak, stop-loss belirlemek ve \u00f6nemli kataliz\u00f6rleri takip etmek \u00f6nerilir."},{"question":"Beam Therapeutics'in teknolojik avantaj\u0131 nedir?","answer":"Beam Therapeutics, baz d\u00fczenleme teknolojisi ile geleneksel CRISPR y\u00f6ntemlerine g\u00f6re daha g\u00fcvenli ve hassas gen d\u00fczenleme sunmaktad\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T17:56:35+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T17:56:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\",\"name\":\"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-20T17:56:35+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T17:56:35+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T17:56:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/","name":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-20T17:56:35+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":342388,"slug":"how-to-buy-beam-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Beam Therapeutics Inc. (BEAM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":342382,"slug":"how-to-buy-beam-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Beam Therapeutics Inc. (BEAM) - Investimento em a\u00e7\u00f5es da Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-beam-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=342387"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342387\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=342387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=342387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=342387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}